glp 1 and ghrelin Schematic depiction of the roles of GLP1 in HG/HL-induced Figure 2 from Ghrelin, CCK,

Many individuals experience energy dips during GLP-1 therapy

The weight loss market is undergoing a seismic shift as the focus moves from injectable peptides to oral small molecule GLP-1 receptor agonists, led by Eli Lillys promising candidate, orforglipron

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 diabetes patients.

#glp1 #breastfeeding

Obviously, it is too early to be overly hopeful since it is still necessary to determine the long-term effects of these compounds and properly verify the potential cardiovascular benefits

Fear no more